Lodoxamide Tromethamine is the tromethamide salt form of lodoxamide, a synthetic mast cell stabilizing compound with anti-inflammatory activity. Upon administration to the eye, lodoxamide tromethamide inhibits type I immediate hypersensitivity reaction by preventing the antigen-stimulated calcium influx into mast cells, thereby inhibiting release of histamine. Lodoxamide tromethamide also prevents the release of slow-reacting substances of anaphylaxis (SRS-A) and inhibits eosinophil chemotaxis. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Alomide and Lodoxamide Trometamol. Its PubChem CID is 11192129.
Lodoxamide tromethamine
| CAS No | 63610-09-3 |
|---|---|
| Molecular Formula | C19H28ClN5O12 |
| Molecular Weight | 553.90 g/mol |
| Synonyms | bis(2-amino-2-(hydroxymethyl)propane-1,3-diol);2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lodoxamide Tromethamine is the tromethamide salt form of lodoxamide, a synthetic mast cell stabilizing compound with anti-inflammatory activity.
The listed CAS number is 63610-09-3.
The listed molecular formula is C19H28ClN5O12.
The listed molecular weight is 553.90 g/mol.
bis(2-amino-2-(hydroxymethyl)propane-1,3-diol);2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid.
The source lists Alomide and Lodoxamide Trometamol.